Evidence map›Paper›PMID 35586622›Full record

ArticleFrontiers in endocrinology2022

Fasting Serum IGFBP-1 as a Marker of Insulin Resistance in Diverse School Age Groups.

Amrit Bhangoo, Rishi Gupta, Steve P Shelov, Dennis E Carey, Siham Accacha, Ilene Fennoy, Lisa Altshuler, Barbara Lowell, Robert Rapaport, Warren Rosenfeld and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 1 country.

Amrit BhangooDivision of Pediatric Endocrinology, Children's Hospital of Orange County, Orange, CA, United States.
Rishi GuptaDivision of Pediatric Endocrinology, Children's Hospital of Orange County, Orange, CA, United States.
Steve P ShelovDepartment of Pediatrics, Winthrop University Hospital, Mineola, NY, United States.
Dennis E CareyDivision of Pediatric Endocrinology, Northwell Health, Lake Success, NY, United States.
Siham AccachaDepartment of Pediatrics, Winthrop University Hospital, Mineola, NY, United States.
Ilene FennoyDivision of Pediatric Endocrinology, New York Presbyterian Morgan Stanley Children's Hospital, New York, NY, United States.
Lisa AltshulerProgram for Medical Education Innovations & Research (PrMeir), New York University (NYU) Grossman School of Medicine, New York, NY, United States.
Barbara LowellLaboratory of Diabetes, Obesity and Other Metabolic Disorders, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States.
Robert RapaportDivision of Pediatric Endocrinology and Diabetes at Mount Sinai Kravis Children's Hospital, New York, NY, United States.
Warren RosenfeldDepartment of Pediatrics, Winthrop University Hospital, Mineola, NY, United States.
Phyllis W SpeiserCohen Children's Medical Center of NY and Zucker School of Medicine, New Hyde Park, NY, United States.
Svetlana TenDivision of Pediatric Endocrinology, Richmond University Medical Center, Staten Island, NY, United States.
Michael RosenbaumDepartment of Pediatrics, Division of Molecular Genetics, New York Presbyterian Medical Center, New York, NY, United States.
Winthrop-University Hospital · USChildren's Hospital of Orange County · USCohen Children's Medical Center · USFeinstein Institute for Medical Research · USMorgan Stanley Children's Hospital · USNewYork–Presbyterian Hospital · USNew York University · USNorthwell Health · USRichmond University Medical Center · USUniversity of Rochester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The known markers of insulin resistance in obese children are well studied. However, they require serial measurements and complicated calculations. The objective is to study IGFBP-1 and its relation with other known risk measures. Materials and Methods: The study included 98 New York City school students of diverse ethnic/racial backgrounds (57 males and 41 females), 11-15 years of age. Subjects were enrolled in a cross-sectional study, and anthropometric measures were collected. They underwent fasting intravenous glucose tolerance tests (IVGTT), and glucose, insulin, lipids, IGFBP-1, adiponectin and inflammatory markers were collected. Results: The subjects were stratified into 3 groups based upon the BMI Z-score. Out of all the subjects, 65.3% were in the group with a BMI Z-score <1 SDS, 16.3% subjects were in the group with a BMI Z-score of 1 to 2 SDS, and 18.4% of the subjects were in the group with a BMI Z-score of more than 2 SDS. The group with a BMI Z-score of more than 2 SDS had increased waist circumference (WC), body fat, increased fasting insulin, and triglycerides (TG). This group had decreased levels of adiponectin and HDL and low IGFBP-1 as compared to the group with BMI <1 SDS. The group with a BMI Z-score of 1 to 2 SDS had a decreased level of IGFBP-1 as compared to the group with a BMI Z-score less than 1 SDS. IGFBP-1 inversely correlated with age, WC, BMI, body fat, TG, and insulin levels. IGFBP-1 positively correlated with adiponectin and HDL levels. Conclusion: IGFBP-1 in children can identify the presence of insulin resistance in the group with BMI 1 to 2 SDS, even before the known markers of insulin resistance such as elevated triglycerides and even before decreased HDL and adiponectin levels are identified.

Indexed as

Insulin ResistancePediatric ObesityAdiponectinAdolescentBiomarkersBody Mass IndexChildCross-Sectional StudiesFastingFemaleHumansInsulinInsulin-Like Growth Factor Binding Protein 1MaleTriglyceridesAdiponectinBiomarkersIGFBP1 protein, humanInsulinInsulin-Like Growth Factor Binding Protein 1TriglyceridesadiposityBMI – body mass indexIGFBP-1insulin resistancewaist circumference

Identifiers

PMID35586622
PMCPMC9108162
OpenAlexW4225285814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.